Idexx Laboratories reported $791.02M in Operating Expenses for its fiscal quarter ending in June of 2026.





Operating Expenses Change Date
Abbott USD 10.46B 1.15B Jun/2026
Accuray USD 37.18M 567K Dec/2024
Align Technology USD 864.87M 2.84M Jun/2026
AngioDynamics USD 81.95M 1.68M Sep/2025
Dentsply International USD 1.32B 895M Mar/2026
Dexcom USD 990.1M 53.5M Jun/2026
Edwards Lifesciences USD 1.22B 87.6M Jun/2026
Fujifilm JPY 825.49B 58.1B Mar/2026
Globus Medical USD 595.85M 49.26M Mar/2026
Henry Schein USD 3.26B 84M Jun/2026
Idexx Laboratories USD 791.02M 12.78M Jun/2026
Inogen USD 49.14M 665K Sep/2024
Insulet USD 672M 32.3M Jun/2026
Integra LifeSciences USD 1.04B 971K Jun/2026
Intuitive Surgical USD 1.91B 3.6M Jun/2026
Neogen USD 222.2M 7.7M Mar/2026
Orthofix International USD 213.79M 12.36M Dec/2025
Phibro Animal Health USD 361.83M 29.47M Mar/2026
ResMed USD 925.74M 525K Mar/2026
Roche Holding CHF 18.9B 2.12B Jun/2026
Steris USD 1.27B 51.5M Mar/2026
Tandem Diabetes Care USD 282.09M 9.97M Dec/2025
Teleflex USD 3.08B 2.55B Mar/2026
Thermo Fisher Scientific USD 9.81B 716M Jun/2026
Zoetis USD 3.23B 1.68B Mar/2026